Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC468

Vamorolón

  • Status:
    Veitt
  • Application date:
    29.5.2024
  • Application published:
    15.6.2024
  • Grant published:
    15.12.2025
  • Max expiry date:
    27.5.2034
  • Medicine name:
    Agamree
  • Medicine for children:
    No

Timeline

Today
29.5.2024Application
15.6.2024Publication
15.12.2025Registration
27.5.2034Expires

Marketing license

  • IS authorization number:
    EU/1/23/1776
  • Date:
    28.12.2023
  • Foreign authorization number:
    EU/1/23/1776
  • Date:
    14.12.2023

Owner

  • Name:
    ReveraGen BioPharma, Inc.
  • Address:
    155 Gibbs Street, Suite 433, Rockville US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Formgallafrestur, fyrsti

Deadline until: 26.09.2024

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents